159 related articles for article (PubMed ID: 15197964)
21. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
[TBL] [Abstract][Full Text] [Related]
22. Long-term survivors with artificial liver support in fulminant hepatic failure.
Nitta M; Hirasawa H; Oda S; Shiga H; Nakanishi K; Matsuda K; Nakamura M; Yokohari K; Hirano T; Hirayama Y; Moriguchi T; Watanabe E
Ther Apher; 2002 Jun; 6(3):208-12. PubMed ID: 12109945
[TBL] [Abstract][Full Text] [Related]
23. [Artificial liver support system for acute-on-chronic liver failure combined with successful liver transplantation in stage III - IV hepatic encephalopathy: an analysis of 14 cases].
Wang YH; Zhu X; Feng DY; Wu BQ
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):676-679. PubMed ID: 30481865
[No Abstract] [Full Text] [Related]
24. Support for the acutely failing liver: a comprehensive review of historic and contemporary strategies.
Barshes NR; Gay AN; Williams B; Patel AJ; Awad SS
J Am Coll Surg; 2005 Sep; 201(3):458-76. PubMed ID: 16125082
[No Abstract] [Full Text] [Related]
25. Artificial liver support at present and in the future.
Onodera K; Sakata H; Yonekawa M; Kawamura A
J Artif Organs; 2006; 9(1):17-28. PubMed ID: 16614798
[TBL] [Abstract][Full Text] [Related]
26. Effect of supportive extracorporeal treatment in liver transplantation recipients and advanced liver failure patients.
Ozdemir FN; Tutal E; Sezer S; Gür G; Bilgic A; Haberal M
Hemodial Int; 2006 Oct; 10 Suppl 2():S28-32. PubMed ID: 17022748
[TBL] [Abstract][Full Text] [Related]
27. Is plasma exchange effective in prevention of hepatic transplantation in fulminant Wilson disease with hepatic failure?
Akyildiz BN; Yildirim S; Kondolot M; Arslan D
J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):778-80. PubMed ID: 21593651
[No Abstract] [Full Text] [Related]
28. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model.
Ho DW; Fan ST; To J; Woo YH; Zhang Z; Lau C; Wong J
Gut; 2002 Jun; 50(6):869-76. PubMed ID: 12010892
[TBL] [Abstract][Full Text] [Related]
29. Continuous Veno-Venous Hemodiafiltration and Plasma Exchange in Infantile Acute Liver Failure.
Ide K; Muguruma T; Shinohara M; Toida C; Enomoto Y; Matsumoto S; Aoki K; Fukuda A; Sakamoto S; Kasahara M
Pediatr Crit Care Med; 2015 Oct; 16(8):e268-74. PubMed ID: 26237654
[TBL] [Abstract][Full Text] [Related]
30. Potential benefits of plasma exchange by apheresis on the treatment of severe Icteric Leptospirosis: case report and literature review.
Cerdas-Quesada C
Transfus Apher Sci; 2011 Oct; 45(2):191-4. PubMed ID: 21889407
[TBL] [Abstract][Full Text] [Related]
31. [Study of severe hepatitis treated with a hybrid artificial liver support system].
Li LJ; Yang Q; Huang JR; Li J; Cao HC; Chen YM; Chen YG; Cheng JF; Fu SZ
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):458-60. PubMed ID: 12939173
[TBL] [Abstract][Full Text] [Related]
32. [Model selection and curative effect judgment criteria for artificial liver in the treatment of liver failure].
Zhou L; Chen Y
Zhonghua Gan Zang Bing Za Zhi; 2022 Feb; 30(2):127-130. PubMed ID: 35359063
[TBL] [Abstract][Full Text] [Related]
33. [The recent progress in blood purification in critical care: overview].
Moriguchi T; Hirasawa H; Oda S; Shiga H; Matsuda K; Hirayama Y
Nihon Rinsho; 2004 May; 62 Suppl 5():397-402. PubMed ID: 15197952
[No Abstract] [Full Text] [Related]
34. [The use of a semiselective method of extracorporeal blood correction for the treatment of patients with disseminated forms of atherosclerosis requiring intensive therapy].
Gendel' LL; Belotserkovskiĭ MV; Gurevich KIa; Strashnov VI; Kostiuchenko AL; Dmitrakova TV; Makeev VM
Anesteziol Reanimatol; 1994; (2):53-6. PubMed ID: 8060002
[No Abstract] [Full Text] [Related]
35. [Clinical application of plasmapheresis in liver failure].
Hamabe S; Komoriyama H; Hamaguchi M; Kubota S; Watanabe H; Idezuki Y
Nihon Rinsho; 1984 Aug; 42(8):1845-9. PubMed ID: 6513054
[No Abstract] [Full Text] [Related]
36. [Liver and artificial liver].
Chamuleau RA
Ned Tijdschr Geneeskd; 1998 Jun; 142(23):1300-5. PubMed ID: 9752034
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal blood purification in the management of patients with hepatic failure.
Kaplan AA; Epstein M
Semin Nephrol; 1997 Nov; 17(6):576-82. PubMed ID: 9353867
[TBL] [Abstract][Full Text] [Related]
38. [Living donor liver transplantation for fulminant hepatic failure--medical treatment organization in Kyushu University].
Suehiro T; Shimada M; Kishikawa K; Soejima Y; Yoshizumi T; Maehara Y; Nakao R; Hayashida K; Nakamuta M; Honda H; Irita K; Kodama K; Inaba S; Taniyama T
Fukuoka Igaku Zasshi; 2002 Aug; 93(8):141-52. PubMed ID: 12382413
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease.
Jhang JS; Schilsky ML; Lefkowitch JH; Schwartz J
J Clin Apher; 2007 Feb; 22(1):10-4. PubMed ID: 17285615
[TBL] [Abstract][Full Text] [Related]
40. Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration.
Yorgin PD; Eklund DK; al-Uzri A; Whitesell L; Theodorou AA
Pediatr Nephrol; 2000 Jan; 14(1):18-21. PubMed ID: 10654323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
